Here we focused on further investigating dimeric versions of these agonistic agents in pancreatic cancer cells, compared to a dimeric natural ligand (ephrinA1-Fc) and to EphA2 knockout cells. The gene discussed is EPHA2; the disease is pancreatic neoplasm.